×

CellRapeutics™ CD19+ B Cells from Human Immunodeficiency Virus HIV Donor (XS-0426-XU3)

Online Inquiry  Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product is composed of B cells isolated from the peripheral blood of HIV-positive donors. These cells are indispensable for researchers focusing on humoral immunity under chronic viral stress, offering a high-quality model to study B cell exhaustion, hyperactivation, and the mechanisms of broadly neutralizing antibody development in a compromised host environment.

Specific Inquiry

  • Size:
  Add to Cart

Donor Information

  • Product Name
  • CellRapeutics™ CD19+ B Cells from Human Immunodeficiency Virus HIV Donor
  • Cat. No.
  • XS-0426-XU3
  • Donor Age
  • Young Adult, Middle-Aged
  • Donor Health
  • Confirmed positive for HIV-1 or HIV-2 infection. Donors are categorized based on their viral load and CD4+ T-cell counts, reflecting a compromised immune state and altered B-cell homeostasis.
  • Ethnicity
  • Diverse backgrounds available.
  • Anticoagulant
  • Heparin or Acid Citrate Dextrose, formulated to stabilize fragile lymphocyte membranes and prevent premature cell lysis common in chronic viral infections during prolonged processing.
  • Additional Donor Information
  • Each lot features CD19+ B cells from HIV-seropositive donors. Comprehensive data include viral load, CD4+ T-cell counts, and duration of Antiretroviral Therapy, enabling researchers to investigate B-cell exhaustion and humoral immune dysfunction in chronic viral infection.
  • Clinical Profile
  • Current viral load, CD4+ T-cell count, duration of infection, and antiretroviral therapy history/status.

Additional Information

  • Medication History
  • Available upon request. Focuses on Antiretroviral Therapy history, including regimen duration, viral load suppression status, and any history of opportunistic infection prophylaxis.
  • Formulation
  • Cryopreserved in specialized freezing medium
  • Cell Purity
  • >90%
  • Cell Viability
  • >90%
  • Mycoplasma Testing
  • Negative
  • Sterility Testing
  • Negative
  • Genetic Stability Testing
  • The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.
  • Application
  • Drug Discovery, Immuno-oncology Research
  • Research Use Only
  • RUO
  • Quality Control
  • Each product batch undergoes rigorous testing for purity, viability, and microbial contamination.
  • Storage
  • Upon arrival, immediately transfer the vial to the liquid nitrogen.
  • Shiping
  • Dry Ice
  • Handling Notes
  • Upon thawing, it is recommended to rapidly thaw the cells in a 37°C water bath, followed by the slow addition of pre-warmed culture medium to minimize osmotic shock.
  • Warnings
  • Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.
  • Size
  • 1E7 cells/vial, 2.5E7 cells/vial
  • Keywords
  • CellRapeutics™ CD19+ B Cells from Human Immunodeficiency Virus HIV Donor, CD19+ B Cells, Human Immunodeficiency Virus HIV

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ CD19+ B Cells from Human Immunodeficiency Virus HIV Donor (XS-0426-XU3). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.